Drug susceptibility and molecular epidemiology of Escherichia coli in bloodstream infections in Shanghai, China, 2011–2013

References

• Leistner R, Sakellariou C, Gürntke S, Kola A, Steinmetz I, Kohler C, et al. Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection. Infect Drug Resist 2014;7:57–62.
   Web of Science ®Google Scholar
• Hounsom L, Grayson K, Melzer M. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteremia. Postgrad Med J 2011;87:757–62.
   PubMedGoogle Scholar
• Laupland KB, Kibsey PC, Gregson DB, Galbraith JC. Population-based laboratory assessment of the burden of community-onset bloodstream infection in Victoria, Canada. Epidemiol Infect 2013;141:174–80.
   Google Scholar
• Gagliotti C, Balode A, Baquero F, Degener J, Grundmann H, Gur D, et al. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill 2011;16:19819.
   PubMedGoogle Scholar
• Schlackow I, Stoesser N, Walker AS, Crook DW, Peto TE, Wyllie DH. Infections in Oxfordshire Research Database Team: increasing incidence of Escherichia coli bacteremia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999--2011. J Antimicrob Chemother 2012;67:1514–24.
   Google Scholar
• Ma XZ, Lv Y, Zheng B. Ministry of Health National Antimicrobial Resistance Investigation Net annual report of 2011: bacterial distribution and resistance in bloodstream infection. Chin J Clin Pharmacol 2012;28:927–32.
   Google Scholar
• Yang ZY, Zhan SY, Wang B, Lv XZ, Shu Z, He YJ, et al. Fatality and secular trend of bloodstream infections during hospitalization in China: a systematic review and meta-analysis. J Peking University (Health Sciences) 2010;42:304–7.
   Google Scholar
• Tumbarello M, Spanu T, Di Bidino R, Marchetti M, Ruggeri M, Trecarichi EM, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother 2010;54:4085–91.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement M100-S23. Wayne, PA: CLSI; 2013.
   Google Scholar
• Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended- spectrum (beta) lactamases. J Antimicrob Chemother 2006; 57:154–5.
   PubMed Web of Science ®Google Scholar
• Kim J, Lim YM, Jeong YS, Seol SY. Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum beta-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrob Agents Chemother 2005;49:1572–5.
   PubMed Web of Science ®Google Scholar
• Jin FX, Yu JH, Mi ZX. β-Lactamase genes and virulence genes in Escherichia coli isolated from old patients. Chinese Journal of Nosocomiology 2009;19:374–6.
   Google Scholar
• Pang F, Li YH, Jia XQ, Zhao QG. Drug resistance and genotype analysis of carbapenem-resistant Enterobacteriaceae. Chin J Clin Lab Sci 2013;31:307–9.
   Google Scholar
• Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000;66:4555–8.
   PubMed Web of Science ®Google Scholar
• Lau SH, Reddy S, Cheesbrough J, Bolton FJ, Willshaw G, Cheasty T, et al. Major uropathogenic Escherichia coli strain isolated in the northwest of England by multilocus sequence typing. J Clin Microbiol 2008;46:1076–80.
   PubMed Web of Science ®Google Scholar
• Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol 2004;186:1518–30.
   PubMed Web of Science ®Google Scholar
• Perez F, Endimiani A, Hujer KM, Bonomo RA. The continuing challenge of ESBLS. Curr Opin Pharmacol 2007;7:459–69.
   PubMed Web of Science ®Google Scholar
• Coque TM, Barquero F, Canton R. Increasing prevalence of ESBL producing Enterobacteriaceae in Europe (abstract). Euro Surveill 2008;13:19044.
   PubMedGoogle Scholar
• Paterson DL, Bonomo RA. Extended spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005;18:657–86.
   PubMed Web of Science ®Google Scholar
• Shin J, Kim DH, Ko KS. Comparison of CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremia. J Infect 2011;63:39–47.
   Google Scholar
• Sun Y, Zeng Z, Chen S, Ma J, He L, Liu Y, et al. High prevalence of blaCTX-M extended-spectrum-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect 2010; 16:1475–81.
   PubMed Web of Science ®Google Scholar
• Zheng H, Zeng Z, Chen S, Liu Y, Yao Q, Deng Y, et al. Prevalence and characterisation of CTX-M-lactamases amongst Escherichia coli isolates from healthy food animals in China. Int J Antimicrob Agents 2012;39:305–10.
   PubMed Web of Science ®Google Scholar
• Kiratisin P, Apisarnthanarak A, Saifon P, Laesripa C, Kitphati R, Mundy LM. The emergence of a novel ceftazidime-resistant CTX-M extended spectrum β-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn Microbiol Infect Dis 2007;58:349–55.
   PubMed Web of Science ®Google Scholar
• Sjölund-Karlsson M, Howie R, Krueger A, Rickert R, Pecic G, Lupoli K, et al. CTX-M-producing non-Typhi Salmonella spp. isolated from humans, United States. Emerg Infect Dis 2011;17:97–9.
   Google Scholar
• Lee W, Chung HS, Lee H, Yun JH, Yong D, Jeong SH, et al. CTX-M-55-type extended-spectrum β-lactamase producing Shigella sonnei isolated from a Korean patient who had travelled to China. Ann Lab Med 2013;33:141–4.
   PubMed Web of Science ®Google Scholar
• Kola A, Kohler C, Pfeifer Y, Schwab F, Kühn K, Schulz K, et al. High prevalence of extended spectrum-β-lactamase-producing Enterobacteriaceae in organic and conventional retail chicken meat, Germany. J Antimicrob Chemother 2012;67:2631–4.
   PubMed Web of Science ®Google Scholar
• Poirel L, Gniadkowski M, Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3. J Antimicrob Chemother 2012;50:1031–4.
   Google Scholar
• Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Caniça MM, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTXM-15. J Antimicrob Chemother 2008;61:273–81.
   PubMed Web of Science ®Google Scholar
• Novais Â, Vuotto C, Pires J, Montenegro C, Donelli G, Coque TM, et al. Diversity and biofilm-production ability among isolates of Escherichia coli phylogroup D belonging to ST69, ST393 and ST405 clonal groups. BMC Microbiol 2013;13:144.
   Google Scholar
• Colomer-Lluch M, Mora A, López C, Mamani R, Dahbi G, Marzoa J, et al. Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain. J Antimicrob Chemother 2013;68:758–65.
   Google Scholar
• Platell JL, Trott DJ, Johnson JR, Heisig P, Heisig A, Clabots CR, et al. Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia. Antimicrob Agents Chemother 2012;56:3898–904.
   PubMedGoogle Scholar
• Crémet L, Caroff N, Giraudeau C, Reynaud A, Caillon J, Corvec S. Detection of clonally related Escherichia coli isolates producing different CMY β-lactamases from a cystic fibrosis patient. J Antimicrob Chemother 2013;68:1032–5.
   PubMedGoogle Scholar